A primer on harnessing non-enzymatic post-translational modifications for drug design
Literature Information
Publication Date
2021-10-26
DOI
10.1039/D1MD00157D
Impact Factor
0
Authors
Marcus J. C. Long, Phillippe Ly, Yimon Aye
View Original
Abstract
Of the manifold concepts in drug discovery and design, covalent drugs have re-emerged as one of the most promising over the past 20-or so years. All such drugs harness the ability of a covalent bond to drive an interaction between a target biomolecule, typically a protein, and a small molecule. Formation of a covalent bond necessarily prolongs target engagement, opening avenues to targeting shallower binding sites, protein complexes, and other difficult to drug manifolds, amongst other virtues. This opinion piece discusses frameworks around which to develop covalent drugs. Our argument, based on results from our research program on natural electrophile signaling, is that targeting specific residues innately involved in native signaling programs are ideally poised to be targeted by covalent drugs. We outline ways to identify electrophile-sensing residues, and discuss how studying ramifications of innate signaling by endogenous molecules can provide a means to predict drug mechanism and function and assess on- versus off-target behaviors.
Related Literature
Determination of paramagnetic concentrations inside a diamagnetic matrix using solid-state NMR
Sébastien Maron, Nadège Ollier, Thierry Gacoin, Géraldine Dantelle
2017-04-11
Paper
DOI: 10.1039/C7CP00451F
Rational molecular design enhancing the photonic performance of red-emitting perylene bisimide dyes
E. Avellanal-Zaballa, G. Durán-Sampedro, A. Prieto-Castañeda, A. R. Agarrabeitia, I. García-Moreno, I. López-Arbeloa, J. Bañuelos, M. J. Ortiz
2017-04-25
Paper
DOI: 10.1039/C7CP01626C
The rotational dynamics of H2 adsorbed in covalent organic frameworks
Tony Pham, Katherine A. Forrest, Matthew Mostrom, Joseph R. Hunt, Hiroyasu Furukawa, Brian Space
2017-04-28
Paper
DOI: 10.1039/C7CP00924K
Understanding nanoparticle porosity via nanoimpacts and XPS: electro-oxidation of platinum nanoparticle aggregates
Xue Jiao, Eden E. L. Tanner, Stanislav V. Sokolov, Robert G. Palgrave, Neil P. Young, Richard G. Compton
2017-05-10
Paper
DOI: 10.1039/C7CP01737E
Understanding doping strategies in the design of organic electrode materials for Li and Na ion batteries: an electronic structure perspective
Johann Lüder, Mun Ho Cheow, Sergei Manzhos
2017-05-10
Paper
DOI: 10.1039/C7CP01554B
Back-exchange: a novel approach to quantifying oxygen diffusion and surface exchange in ambient atmospheres
Samuel J. Cooper, Mathew Niania, Franca Hoffmann, John A. Kilner
2017-04-27
Paper
DOI: 10.1039/C7CP01317E
Electron transfer in silicon-bridged adjacent chromophores: the source for blue-green emission
Malgorzata Bayda, Gonzalo Angulo, Jerzy Karolczak, Jacek Koput, Jacek Dobkowski, Bronislaw Marciniak
2017-04-03
Paper
DOI: 10.1039/C7CP00590C
Intracellular-molecular changes in plasma-irradiated budding yeast cells studied using multiplex coherent anti-Stokes Raman scattering microscopy
Ryo Furuta, Naoyuki Kurake, Kenji Ishikawa, Keigo Takeda, Hiroshi Hashizume, Hiroki Kondo, Takayuki Ohta, Masafumi Ito, Makoto Sekine, Masaru Hori
2017-04-27
Communication
DOI: 10.1039/C7CP00489C
Phonons spreading from laser-heated gold nanoparticle array accelerate diffusion of excitons in an underlying polythiophene thin film
David Rais, Miroslav Menšík, Bartosz Paruzel, Dharmalingam Kurunthu, Jiří Pfleger
2017-03-24
Paper
DOI: 10.1039/C7CP00286F
You might also like
Compound Q&A
How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?
Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...
898825-89-3N-Methoxy-N-methyl-1...
Compound Q&A
How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?
N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...
1318338-47-4N-(4-Biphenylyl)dibe...
Compound Q&A
What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?
The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...
1713-07-13-Acetamido-5-amino-...
Compound Q&A
How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?
Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...
61820-03-9Benzyl 2-O-acetyl-3,...
Compound Q&A
What regulatory guidelines apply to 2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3)?
2-Ethylpiperazine dihydrochloride (CAS: 438050-52-3) is regulated under the Glob...
438050-52-32-Ethylpiperazine di...
Compound Q&A
What regulatory guidelines apply to 1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 119462-56-5)?
1,1'-[1,3-Phenylenebis(methylene)]bis(3-methyl-1H-pyrrole-2,5-dione) (CAS: 11946...
119462-56-51,1'-[1,3-Phenyleneb...
Compound Q&A
Are there alternatives to 5-Fluoro-2-(1-pyrrolidinyl)pyridine (CAS: 1287217-79-1) in synthesis?
Several alternatives can be used in the synthesis of 5-Fluoro-2-(1-pyrrolidinyl)...
1287217-79-15-Fluoro-2-(1-pyrrol...
Compound Q&A
What precautions should be taken when handling 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione (CAS: 153631-19-7)?
Proper personal protective equipment (PPE) must be worn when handling this compo...
153631-19-71-((2R,3R,4R,5R)-5-(...
Compound Q&A
What precautions should be taken when handling 6-Bromoimidazo[1,2-a]pyridin-8-amine (CAS: 676371-00-9)?
When handling 6-Bromoimidazo[1,2-a]pyridin-8-amine, it is important to wear appr...
676371-00-96-Bromoimidazo[1,2-a...
Compound Q&A
Are there alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochloride (CAS: 1049740-22-8) in synthesis?
Alternatives to (2S,4R)-4-(4-Nitrobenzyl)pyrrolidine-2-carboxylic acid hydrochlo...
1049740-22-8(2S,4R)-4-(4-Nitrobe...
Source Journal
Recommended Compounds
(3beta,7beta,12beta)-3,7,12-Trihydroxy-11,15,23-trioxolanost-8-en-26-oic acid
CAS Number:
98665-22-6
Molecular Formula:
C30H44O8
1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
CAS Number:
1020174-04-2
Molecular Formula:
C10H17BN2O2
Recommended Suppliers
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.